Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Note on the offering

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Jan 14, 2021 3:34pm

157 Views

Post# 32299024

RE:RE:Note on the offering

Well the good thing is then the warrant holder needs to keep it and also find the document and send it to his broker sometime within 3 years. Wouldn't surprise me 10-15% never get exercised, maybe more.

SABBOBCAT wrote: I realize not that there was a term sheet revision, hence the edits. Still blinded by anger on the offering I guess. Also, why not list the warrants? That's a disappointing change.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?